Class-level drug safety surveillance in hospital practice: A pharmacovigilance analysis of 84 therapeutic subclasses from a South Asian tertiary care center

Safety Actions Common With Fast-Track Cancer Drugs

Beyond the Bookshelf: Transforming Drug Information Resources through Digital Innovation

Exploring adverse events associated with vosoritide monotherapy: Insights from the FDA Adverse Event Reporting System

Cardiac disorders associated with compound long-acting bronchodilators for inhalation: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database

Are We Missing Dangerous Drug Interactions? Pharmacist-Led Telehealth Raises Red Flags in Oncology Care

Pediatric IBD: Combination Therapy Linked to Increased Skin Infection Risk

Efficacy and safety of delayed thrombolysis for ischemic stroke within 4.5–24 h: A systematic review and meta-analysis of randomized controlled trials

Inteligencia artificial en medicina: una guía ética y práctica para la asistencia sanitaria, la investigación y la docencia

Overview of counterfeiting in performance-enhancing drugs used in enhanced bodybuilding

Preliminary Quality Evaluation of New Generic Brands of Ciprofloxacin

El Invima alerta sobre la venta ilegal de cápsulas “anti-alopecia”

We need a standardized North American acetylcysteine dosing regimen for the treatment of paracetamol (acetaminophen) poisoning

Reducing delays in time-critical medications for Parkinson's disease: a multifaceted, multiprofessional quality improvement project

FDA Requests Removal of Suicidal Ideation Warning From GLP-1 RA Medications

Rethinking anti-cancer drug discovery: the evolution from polypharmacy to unified drug units

Drug-associated deep vein thrombosis: a disproportionality analysis of the FDA adverse event reporting system (FAERS) database